Yigal Nochomovitz
Stock Analyst at Citigroup
(2.27)
# 2,615
Out of 4,876 analysts
299
Total ratings
38.3%
Success rate
-1.53%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yigal Nochomovitz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SLDB Solid Biosciences | Initiates: Buy | $14 | $4.77 | +193.50% | 1 | Jun 26, 2025 | |
| APLS Apellis Pharmaceuticals | Maintains: Buy | $49 → $41 | $18.35 | +123.43% | 15 | May 22, 2025 | |
| KRYS Krystal Biotech | Maintains: Neutral | $215 → $155 | $141.99 | +9.17% | 5 | May 16, 2025 | |
| ARVN Arvinas | Maintains: Neutral | $10 → $9.5 | $7.79 | +21.95% | 10 | May 5, 2025 | |
| ARDX Ardelyx | Maintains: Buy | $11 → $10 | $3.71 | +169.91% | 15 | May 2, 2025 | |
| SMMT Summit Therapeutics | Upgrades: Buy | $23 → $35 | $21.26 | +64.63% | 5 | Mar 26, 2025 | |
| LENZ LENZ Therapeutics | Maintains: Buy | $44 → $47 | $30.02 | +56.59% | 2 | Mar 20, 2025 | |
| ZYME Zymeworks | Maintains: Buy | $18 → $19 | $12.40 | +53.29% | 16 | Mar 7, 2025 | |
| RIGL Rigel Pharmaceuticals | Maintains: Buy | $49 → $55 | $18.86 | +191.70% | 11 | Mar 6, 2025 | |
| SNDX Syndax Pharmaceuticals | Maintains: Buy | $45 → $42 | $9.34 | +349.68% | 8 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $5.08 | +392.13% | 1 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $89 → $82 | $47.00 | +74.47% | 21 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $33 | $9.97 | +230.99% | 1 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $89 → $97 | $53.07 | +82.79% | 16 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $8 | $0.37 | +2,069.79% | 10 | Nov 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $6 | $1.33 | +351.13% | 5 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $10.11 | +167.06% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $8 → $2 | $0.99 | +102.96% | 4 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $36 | $22.74 | +58.31% | 2 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $58 | $22.14 | +161.97% | 3 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $22 | $1.93 | +1,039.90% | 8 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $14 | $1.27 | +1,002.80% | 14 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.5 → $1.2 | $0.34 | +258.10% | 9 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $38 | $8.53 | +345.49% | 7 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $14 | $10.29 | +36.05% | 6 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.8 → $2 | $2.21 | -9.30% | 3 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $123 → $66 | $34.82 | +89.55% | 8 | Feb 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $48 | $14.46 | +231.95% | 5 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $4.61 | +334.00% | 1 | Jan 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $8 | $3.90 | +105.13% | 10 | Oct 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.5 → $1 | $3.21 | -68.85% | 4 | Sep 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $50 → $35 | $7.94 | +340.81% | 12 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $130 → $133 | $37.52 | +254.48% | 15 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $8 | $0.90 | +784.76% | 11 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $6 | $0.78 | +669.23% | 7 | May 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $16 | $1.44 | +1,011.11% | 3 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $10 | $1.08 | +825.93% | 6 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $0.72 | +2,136.20% | 1 | Oct 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $44 | $3.41 | +1,190.32% | 2 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $12 | $1.88 | +538.30% | 1 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $3.32 | - | 14 | Sep 28, 2021 |
Solid Biosciences
Jun 26, 2025
Initiates: Buy
Price Target: $14
Current: $4.77
Upside: +193.50%
Apellis Pharmaceuticals
May 22, 2025
Maintains: Buy
Price Target: $49 → $41
Current: $18.35
Upside: +123.43%
Krystal Biotech
May 16, 2025
Maintains: Neutral
Price Target: $215 → $155
Current: $141.99
Upside: +9.17%
Arvinas
May 5, 2025
Maintains: Neutral
Price Target: $10 → $9.5
Current: $7.79
Upside: +21.95%
Ardelyx
May 2, 2025
Maintains: Buy
Price Target: $11 → $10
Current: $3.71
Upside: +169.91%
Summit Therapeutics
Mar 26, 2025
Upgrades: Buy
Price Target: $23 → $35
Current: $21.26
Upside: +64.63%
LENZ Therapeutics
Mar 20, 2025
Maintains: Buy
Price Target: $44 → $47
Current: $30.02
Upside: +56.59%
Zymeworks
Mar 7, 2025
Maintains: Buy
Price Target: $18 → $19
Current: $12.40
Upside: +53.29%
Rigel Pharmaceuticals
Mar 6, 2025
Maintains: Buy
Price Target: $49 → $55
Current: $18.86
Upside: +191.70%
Syndax Pharmaceuticals
Mar 4, 2025
Maintains: Buy
Price Target: $45 → $42
Current: $9.34
Upside: +349.68%
Feb 20, 2025
Initiates: Buy
Price Target: $25
Current: $5.08
Upside: +392.13%
Feb 18, 2025
Maintains: Buy
Price Target: $89 → $82
Current: $47.00
Upside: +74.47%
Jan 7, 2025
Initiates: Buy
Price Target: $33
Current: $9.97
Upside: +230.99%
Dec 9, 2024
Maintains: Buy
Price Target: $89 → $97
Current: $53.07
Upside: +82.79%
Nov 29, 2024
Maintains: Buy
Price Target: $13 → $8
Current: $0.37
Upside: +2,069.79%
Nov 26, 2024
Maintains: Buy
Price Target: $30 → $6
Current: $1.33
Upside: +351.13%
Oct 8, 2024
Initiates: Buy
Price Target: $27
Current: $10.11
Upside: +167.06%
Oct 2, 2024
Downgrades: Neutral
Price Target: $8 → $2
Current: $0.99
Upside: +102.96%
Sep 11, 2024
Maintains: Buy
Price Target: $30 → $36
Current: $22.74
Upside: +58.31%
Aug 27, 2024
Maintains: Buy
Price Target: $60 → $58
Current: $22.14
Upside: +161.97%
Aug 27, 2024
Maintains: Buy
Price Target: $45 → $22
Current: $1.93
Upside: +1,039.90%
Aug 15, 2024
Maintains: Buy
Price Target: $16 → $14
Current: $1.27
Upside: +1,002.80%
Jun 18, 2024
Maintains: Neutral
Price Target: $3.5 → $1.2
Current: $0.34
Upside: +258.10%
Jun 3, 2024
Maintains: Buy
Price Target: $36 → $38
Current: $8.53
Upside: +345.49%
May 7, 2024
Maintains: Buy
Price Target: $15 → $14
Current: $10.29
Upside: +36.05%
Apr 18, 2024
Maintains: Neutral
Price Target: $1.8 → $2
Current: $2.21
Upside: -9.30%
Feb 29, 2024
Maintains: Buy
Price Target: $123 → $66
Current: $34.82
Upside: +89.55%
Feb 8, 2024
Maintains: Buy
Price Target: $40 → $48
Current: $14.46
Upside: +231.95%
Jan 30, 2024
Initiates: Buy
Price Target: $20
Current: $4.61
Upside: +334.00%
Oct 17, 2023
Maintains: Buy
Price Target: $25 → $8
Current: $3.90
Upside: +105.13%
Sep 18, 2023
Maintains: Neutral
Price Target: $1.5 → $1
Current: $3.21
Upside: -68.85%
Aug 21, 2023
Maintains: Sell
Price Target: $50 → $35
Current: $7.94
Upside: +340.81%
Jun 7, 2023
Maintains: Buy
Price Target: $130 → $133
Current: $37.52
Upside: +254.48%
May 31, 2023
Maintains: Buy
Price Target: $6 → $8
Current: $0.90
Upside: +784.76%
May 26, 2023
Maintains: Buy
Price Target: $5 → $6
Current: $0.78
Upside: +669.23%
Apr 5, 2023
Maintains: Buy
Price Target: $24 → $16
Current: $1.44
Upside: +1,011.11%
Mar 2, 2023
Maintains: Buy
Price Target: $9 → $10
Current: $1.08
Upside: +825.93%
Oct 14, 2022
Initiates: Buy
Price Target: $16
Current: $0.72
Upside: +2,136.20%
Sep 16, 2022
Maintains: Buy
Price Target: $45 → $44
Current: $3.41
Upside: +1,190.32%
Sep 16, 2022
Maintains: Buy
Price Target: $16 → $12
Current: $1.88
Upside: +538.30%
Sep 28, 2021
Upgrades: Buy
Price Target: n/a
Current: $3.32
Upside: -